Application Sponsors
ANDA 090923 | SUN PHARM INDS LTD | |
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | EQ 500MG BASE/VIAL | 0 | AZITHROMYCIN | AZITHROMYCIN |
FDA Submissions
| ORIG | 1 | AP | 2013-04-02 | |
LABELING; Labeling | SUPPL | 2 | AP | 2015-03-19 | STANDARD |
LABELING; Labeling | SUPPL | 7 | AP | 2017-02-01 | STANDARD |
LABELING; Labeling | SUPPL | 8 | AP | 2020-04-11 | STANDARD |
LABELING; Labeling | SUPPL | 9 | AP | 2020-04-11 | STANDARD |
LABELING; Labeling | SUPPL | 15 | AP | 2020-04-11 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 19 |
SUPPL | 2 | Null | 7 |
SUPPL | 7 | Null | 7 |
SUPPL | 8 | Null | 15 |
SUPPL | 9 | Null | 15 |
SUPPL | 15 | Null | 7 |
TE Codes
CDER Filings
SUN PHARM INDS LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 90923
[companyName] => SUN PHARM INDS LTD
[docInserts] => ["",""]
[products] => [{"drugName":"AZITHROMYCIN","activeIngredients":"AZITHROMYCIN","strength":"EQ 500MG BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"AZITHROMYCIN","submission":"AZITHROMYCIN","actionType":"EQ 500MG BASE\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)